NASA in nasal spray deal to combat motion sickness

CAPE CANAVERAL, Florida (Reuters) – NASA has signed an agreement with a California-based startup to develop and market a nasal spray for motion sickness, the U.S. space agency said on Friday. NASA will work with privately owned Epiomed Therapeutics of Irvine, California, on the nasal spray, which has been shown to be a fast-acting treatment for motion sickness. About half the astronauts who fly in space develop space motion sickness, with symptoms that anyone nauseated or light-headed from more terrestrial forms of travel will recognize. …